Author: Charlotte Anthony | Category: In The News | Physiology & Pharmacology | Physiology and Pharmacology | April 16, 2015
Nathan Mitchell, a graduate student in the Department of Physiology, placed second in the Neuropharmacology Division “Best Graduate Student Poster Abstract/Award” at the American Society for Pharmacology and Experimental Therapeutics (ASPET) Annual Meeting during Experimental Biology 2015 in Boston.
"The poster competition at Experimental Biology was a great opportunity to network with peers and principal investigators," Mitchell said. "I was happy to receive the award; however, the connections I made that night were really the best part."
Mitchell's presentation garnered one of only seven press releases from the ASPET meeting and highlighted his work to find new biological mechanisms that could treat depression in children more effectively.
According to ASPET, "if researchers can uncover the biological mechanisms preventing available treatments from producing antidepressant effects, scientists can then target those mechanisms to develop new antidepressants that will treat childhood and adolescent depression more effectively."
Mitchell is working in the lab of Dr. Lynette Daws.
“Nathan is a rising star in neuropharmacology and a fantastic
young scientist," Dr. Daws said. "His dissertation research is making major breakthroughs
in the development of improved therapeutics for the treatment of depression in
kids and teens.”
To read the press release, click here.
Copyright © 2019 The University of Texas Health Science Center at San Antonio
Links provided from the UTHSCSA pages to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.